Literature DB >> 28882385

Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients.

Islam O F Moustafa1, Mohammed R A-A Ali2, Moataz Al Hallag3, Hoda Rabea4, James B Fink5, Patricia Dailey6, Mohamed E A Abdelrahim7.   

Abstract

BACKGROUND: During mechanical ventilation medical aerosol delivery has been reported to be upto two fold greater with dry inhaled gas than with heated humidity. Urine levels at 0.5 h post dose (URSAL0.5%) has been confirmed as an index of lung deposition and 24 h (URSAL24%) as index of systemic absorption. Our aim was to determine the effect of humidification and aerosol device type on drug delivery to ventilated patients using urine levels.
METHODS: In a randomized crossover design, 36 (18female) mechanically ventilated patients were assigned to one of three groups. Groups 1 and 2 received 5000 μg salbutamol using vibrating mesh (VM) and jet nebulizers (JN), respectively, while group 3 received 1600 μg (16 puffs) of salbutamol via metered dose inhaler with AeroChamber Vent (MDI-AV). All devices were placed in the inspiratory limb of ventilator downstream from the humidifier. Each subject received aerosol with and without humidity at >24 h intervals with >12 h washout periods between salbutamol doses. Patients voided urine 15 min before each study dose and urine samples were collected at 0.5 h post dosing and pooled for the next 24 h.
RESULTS: The MDI-AV and VM resulted in a higher percentage of urinary salbutamol levels compared to the JN (p < 0.05). Urine levels were similar between humidity and dry conditions.
CONCLUSIONS: Our findings suggest that in-vitro reports overestimate the impact of dry vs. heated humidified conditions on the delivery of aerosol during invasive mechanical ventilation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Humidification; MDI; Non-invasive ventilation; Spacer; Urinary salbutamol; Vibrating mesh nebulizers

Mesh:

Substances:

Year:  2017        PMID: 28882385     DOI: 10.1016/j.hrtlng.2017.08.004

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  7 in total

Review 1.  Aerosol delivery via noninvasive ventilation: role of models and bioanalysis.

Authors:  Haitham Saeed; Hadeer S Harb; Yasmin M Madney; Mohamed E A Abdelrahim
Journal:  Ann Transl Med       Date:  2021-04

Review 2.  Aerosol delivery via invasive ventilation: a narrative review.

Authors:  Hui-Ling Lin; James B Fink; Huiqing Ge
Journal:  Ann Transl Med       Date:  2021-04

3.  The utilization of aerosol therapy in mechanical ventilation patients: a prospective multicenter observational cohort study and a review of the current evidence.

Authors:  Shan Lyu; Jie Li; Limin Yang; Xiaoliang Du; Xiaoyi Liu; Libo Chuan; Guoqiang Jing; Zhenyan Wang; Weiwei Shu; Chunjuan Ye; Qionglan Dong; Jun Duan; James B Fink; Zhancheng Gao; Zongan Liang
Journal:  Ann Transl Med       Date:  2020-09

4.  Aerosol Delivery to a Critically Ill Patient: A Big Issue Easily Solved by Developing Guidelines.

Authors:  Mohamed E A Abdelrahim
Journal:  Pulm Ther       Date:  2018-07-31

5.  Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis.

Authors:  Bhavya Vishwa; Afrasim Moin; D V Gowda; Syed M D Rizvi; Wael A H Hegazy; Amr S Abu Lila; El-Sayed Khafagy; Ahmed N Allam
Journal:  Pharmaceutics       Date:  2021-01-08       Impact factor: 6.321

Review 6.  Relationship between Change in Bone Mineral Density of Lumbar Spine and Risk of New Vertebral and Nonvertebral Fractures: A Meta-Analysis.

Authors:  Liang Chen; Xiao-Ping Liu; Bo Zhou; Tong-Ya Guo; Feng Yuan; Mohamed E A Abdelrahim; Zhen-Huan Jiang
Journal:  Orthop Surg       Date:  2022-01-04       Impact factor: 2.071

7.  Effect of age of COVID-19 inpatient on the severity of the disease: A meta-analysis.

Authors:  Shaoqing Chai; Yan Li; Xuemei Li; Jie Tan; Mohamed E A Abdelrahim; Xiaoxiao Xu
Journal:  Int J Clin Pract       Date:  2021-08-01       Impact factor: 3.149

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.